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INTRODUCTION 
  
  
LIPID BASED DRUG DELIVERY SYSTEMS  
 
Drugs which are poorly water solubility are made well suitable for lipid-based formulation. 
Water insoluble and weakly basic drugs require special care in the design and development of 
lipid based formulation. These drugs administered in the solubilised form in the lipid vehicle 
may come out of the formulation due to solubilisation in the gastric fluid and may precipitate 
in the intestinal fluid on gastric emptying. The bioavailability of this system would depend on 
how rapidly the precipitates can be resolubilized by the formulation. (Sanjay Singh et al., 
2009). 
The percentage of new chemical entities synthesized with low aqueous solubility and high 
therapeutic efficacy is growing, this presents a major challenge for the drug delivery. To 
overcome the above challenge different methods were developed for the enhancement of 
bioavailability.  
Lipid based formulations are more effective delivery system for oral route and improve 
bioavailability because of its proven safety and efficacy. Lipid Formulation Classification 
System was established by Pouton et al., It aims to enable in vivo studies for interpreting and 
for the identification of the most appropriate formulations for specific drugs, their 
physiochemical properties are taken into consideration. (Maulik Patel et al., 2011) 
 
SOLID LIPID NANOPARTICLES (SLNs): 
 
SLNs are particulate system with particle diameters ranging 50-1000nm. They are derived 
from oil-in-water emulsions, by replacing the liquid oil by a solid lipid. Particle size of SLN 
is in submicron range, ranging from 40 to 1000 nm. They have several advantages that the 
lipid matrix is generally made from physiologically well-tolerated lipid components, which 
decreases the toxicity. They have a stability of around 3 years and can easily be manufactured 
at industrial scales. SLNs, lipid micro particles and lipospheres have been used as alternative 
carriers for therapeutic peptides, proteins and antigens. Formulation as SLNs confers 
improved protein stability, avoids proteolysis, as well as providing sustained release of the 
incorporated molecules. Well-known peptides such as cyclosporine A, insulin, calcitonin and 
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somatostatin have been incorporated into solid lipid particles. (AlkaLohani, Anurag Verma et 
al., 2014). 
NANO STRUCTURED LIPID CARRIER (NLC) 
 
A Nano structured lipid carrier (NLC) are the new generation of lipid nanoparticles, attracting 
major attention as novel colloidal drug carriers which is composed of physiological lipid 
materials suitable for topical, dermal, and transdermal administrations. To illustrate, several 
problems have been reported with the conventional topical preparations, e.g., low uptake due 
to the barrier function of the stratum corneum and unwanted absorption to the systemic 
circulation. Several systems which are provided in literature review can deliver active 
pharmaceutical ingredients across the skin presenting advantages in systemic treatment with 
minimal side effects, the absence of first-pass metabolism, and in topical treatment allowing 
targeting specific skin appendages. NLC has been developed to overcome the drawbacks 
dealing with Solid Lipid Nanoparticles (SLN). SLN is produced by replacing the oil of an 
o/w emulsion by a solid lipid or a blend of solid lipid, i.e., the lipid particle matrix being solid 
at both room and body temperature. NLC consist mixture of solid lipid (long chain) and 
liquid lipid (short chain), preferably in a ratio of 70:30 up to a ratio of 99.9:0.1. The resulting 
matrix of the lipid particle shows a melting point depression compared to the original solid 
lipid, however, the matrix remains solid at body temperature. Some limitation of the SLN 
system regarding drug expulsion during storage, reduced particle concentration, reduced drug 
loading, these limitations were solved by formulating lipid particles with controlled 
nanostructure known as NLC. For some number of drugs, the solubility of liquid lipid is 
higher than that of solid lipid, which enhances drug-loading, NLC possess numerous features 
that are advantageous for the topical route of application. NLC are composed of physiological 
and biodegradable lipids that show low toxicity. The small size ensures a close contact to the 
stratum corneum and can increase the amount of drug penetrated into the skin. Due to the 
occlusive properties of lipid nanoparticles, an increased skin hydration effect is observed. 
Further these lipid nanoparticles are able to enhance the chemical stability of compounds 
sensitive to light, oxidation and hydrolysis. (shaileshpatwekar et al.,2014) 
 
ADVANTAGES OF NLCs 
 
 Their small size and relatively narrow size distribution permits site-specific drug 
delivery. 
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 Controlled and Sustained release of active drug can be achieved. 
 The incorporated drug is protected from the onslaughts of biochemical degradation. 
 High drug payload. 
 Incorporation of lipophilic and hydrophilic drugs feasible. 
 Can be sterilized by autoclave or gamma radiation. 
 Can be lyophilizes and spray dried. 
 Do not generate any toxic metabolites. 
 Relatively cheap and stable. 
 Ease of industrial scale production by hot dispersion technique. 
 Surface modification can be easily performed.  
 
PRODUCTION OF LIPID NANOPARTICULATE DRUG DELIVERY SYSTEM 
There are two basic methods of SLN production: high pressure homogenization (HPH) and 
microemulsion technique. Also, attempts have been made to obtain those compounds using 
less expensive and complicated methods, such as ultrasound technique (US) and solvent cast 
method. Unfortunately, those methods have a number of disadvantages. (ElwiraLanson et al., 
2011) The basic methods of obtaining solid lipid nanoparticles are outlined below. 
 
High Pressure Homogenization (HPH) 
 
HPH has proved to be an effective and reliable method of SLN production. Homogenizers of 
various sizes are available on the market for relatively favourable prices and HPH has been 
used in the production of nano-emulsions for a number of years. Contrary to other technique, 
HPH usually does not pose any difficulties for large-scale production. High-pressure 
homogenizers force the liquid through very thin orifices (a few microns in diameter) under 
the pressure of 100-2000 bar. On very short distances, the liquid reaches very high velocity of 
over 1000 km/h. High turbulence and shear disintegrate the particles to submicron sizes. The 
typical lipid content is 5÷10% and poses no difficulty for the homogenizer. Lipid nano-
dispersion has been achieved with lipid concentration as high as 40%. HPH is further divided 
into hot and cold high pressure homogenization. In both methods the preparatory stage 
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involves the introduction of active substance into the lipids through dissolution or dispersion 
of those substances in liquefied lipid mass.  
 
Hot homogenization technique: 
Hot homogenization is conducted at temperatures higher than lipid melting point and can thus 
be considered homogenization in emulsion. Pre-emulsion of the active substance, melted 
lipid and water phase of the emulsifier is obtained in high speed mixer. The quality of pre-
emulsions largely determines the quality of the end product. The desirable particle sizes are 
within a few micrometres. Hot homogenization of the pre-emulsion is conducted at 
temperature higher than lipid melting point. In general, the higher the temperature, the 
smaller the particle size, caused by viscosity reduction in the internal phase. However, too 
high temperature may cause the active substance and the carrier to decompose. The 
homogenization stage can be repeated a number of times. It should be noted that 
homogenization under increased pressure causes the emulsion temperature to rise by approx. 
10° for every 500 bar. In most cases 3 to 5 homogenization cycles under 500-1,500 bar are 
sufficient. The increase of homogenization pressure or the number of cycles often results in 
the increase in particle size due to coalescence which is the product of high kinetic energy of 
particles. The basis product of hot homogenization is nanoemulsion in liquid state. Solid 
particles are obtained by cooling the sample to room temperature or lower. Due to small 
particle size and the presence of emulsifiers the crystallization of lipids can take very long 
(up to a few months).  
 
Cold homogenization technique: 
 
In the cold homogenization method, the lipid microparticles are obtained by melting and 
subsequent cooling of drug containing lipid followed by crushing, grounding and that is 
diffused in cold surfactant to obtain a cold pre-suspension of micronized lipid particles. This 
suspension is then passes through a high pressure homogenizer at room temperature by 
applying 5–10 cycles at 1500 bar. This method is most suitable for hydrophilic drugs with 
low solubility (surfactants are added to improve solubility). This technique shortens melting 
process of lipid and hence it is useful for thermo-sensitive and thermo-labile drugs. 
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Cold homogenization has been developed in order to overcome the three fundamental 
problems of hot homogenization:          
 Decomposition of the active substance, caused by high temperature 
 Decomposition of the active substance in the water phase duringhomogenization 
 Complexity of the crystallization stage of the nanoemulsion, leading to 
multiplemodifications. 
 
 
Fig 1: Schematic procedure of homogenization techniques for SLN production 
 
 
Microemulsion technique 
 
In order to obtain microemulsion with lipids in solid state at room temperature, the process 
temperature must be higher than lipid melting point. Lipids (e.g. fatty acids and/or 
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triglycerides) are melted and the mixture of water, emulsifiers and co-emulsifiers is heated to 
the temperature of the lipids and blended under mild conditions. If the procedure runs 
correctly, we will obtain transparent, thermodynamicallystable complex. The hot 
microemulsion is then dispersed in chilled water (2÷3°C) by smooth mechanical stirring, 
which ensures that the small particle size results from precipitation and not the mechanical 
stirring. The volume ratio of hot microemulsion to cold water should be from 1:25 to 1:50. 
The most popular emulsifiers are polysorbate 20, polysorbate 60 and soy lecithin. The most 
frequently used co-emulsifiers are usually alcohols, e.g. butanol. Technically, the 
precipitation of lipid particles in water is equivalent to diluting the complex, which leads to 
decrease in solid substance content in SLN dispersion. Due to diluting stage the achievable 
lipid content is lower than in formulations obtained through HPH. (ElwiraLanson et al.,2011). 
 
 
 
 
Fig 2: Schematic diagram showing the structures formed duringthe production of SLN 
by microemulsion technique 
 
 
NUTRACEUTICALS 
        The quality of life in terms of income, spending and lifestyle has improved with 
economic Development. However, it has also thrown up a major challenge in the form of 
lifestyle Diseases'. The first victim of this lifestyle change has been food habits. Consumption 
of junk food has increased manifold, which has led to a number of diseases related to 
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nutritional deficiencies. Nutraceuticals can play an important role in controlling them. No 
wonder more and more people are turning to nutraceuticals. The term nutraceuticals was 
coined from nutrition and pharmaceutical in 1989by Stephen Defelice, founder and chairman 
of foundation for innovation in medicine, an American organization which encourages 
medical health [1, 2, 3, 4]. According to him “a nutraceutical is any substance that is a food 
or apart of food and provides medical or health benefits, including the prevention and 
treatment of disease”. Such products may range from isolated nutrients, dietary supplements 
and specific diets to genetically engineered designer foods and herbal products. The concept 
of nutraceutical was stared from the survey in U.K., Germany and France and it concluded 
that diet is rated more highly by consumer then exercise or hereditary factors to achieving a 
good health. In the U.S. “nutraceutical"Was commonly used, but no regulatory definition 
existed. Its meaning was modified by health ministry of Canada which defines nutraceutical 
as “a product isolated or purified from the food, generally sold in medicinal form not 
associated with food and demonstrated to have a physiological benefit .It also provides 
benefit against chronic disease. 
        In Britain, the Ministry of Agriculture, Fisheries and Food has developed a definition of 
a functional food as "a food that has a component incorporated into it to give it a specific 
medical or physiological benefit, other than purely nutritional benefit [8].There is a slight 
difference between the functional foods and nutraceuticals. When food is being cooked or 
prepared using "scientific intelligence" with or without knowledge of how or why it is being 
used, the food is called “functional food". Thus, functional food provides the body with the 
required amount of vitamins, fats, proteins, carbohydrates, etc. needed for its healthy 
survival. When functional food aids in the prevention and/or treatment of disease(s) and/or 
disorder(s) other than anemia, it is called a nutraceutical. Examples of nutraceuticals include 
fortified dairy products (e.g. milk) and citrus fruits (e.g. orange juice). 
BENEFITS 
• May increase the health value of our diet. 
• May help us live longer. 
• May help us to avoid particular medical conditions. 
• May have a psychological benefit from doing something for oneself. 
• May be perceived to be more "natural" than traditional medicine and less likely to produce            
unpleasant side-effects. 
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• May present food for populations with special needs (e.g. nutrient-dense foods for the 
elderly) 
 
CLASSIFICATION OF NUTRACEUTICALS 
        Regarding the promise of nutraceuticals, they should be considered in two ways: 
• Potential nutraceuticals 
• Established nutraceuticals 
A potential nutraceuticals is one that holds a promise of a particular health or medical benefit; 
such a potential nutraceuticals only becomes an established done after there are sufficient 
clinical data to demonstrate such a benefit. It is disappointing to note that the over whelming 
majority of nutraceuticals products are in the 'potential' category, waiting to become 
established. The food products used as nutraceuticals are categorized as 
• Probiotic 
• Prebiotic 
• Dietary fiber 
• Omega 3 fatty acid 
• Antioxidant 
 
ADVANTAGES OF ESSENTIAL OIL IN COSMETICEUTICAL FORMULATION 
 
1. Enhancing the dermato-cosmetic properties and preservation, as well as the marketing 
image of the product. 
2. At relatively high concentration in cosmetics it provides skin benefit. 
 
NIACINAMIDE 
 
Niacinamide is a derivative of vitamine B3 that suppresses melanin from reaching the surface 
of the skin and protects the skin from further UV damage. Niacinamide is a very effective 
skin-restoring ingredient that offers multiple benefits for aging skin, has been found to 
soothing activity which may be useful for blemished skin. Can improve the appearance of 
aged , hyperpigmented , and photodamaged  skin. Niacinamide is categorized as BCS class I 
drugs owing to its poor aqueous solubility and poor GI absorption. In the present context, 
development of cosmeceutical with natural preservation system will be beneficial for the 
broad application and development of cosmeceutical. The present investigation is focused on 
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the development and optimization of natural preservation system and development of 
cosmetic loaded with nano lipid carrier with cosmeceutical.   
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OBJECTIVE 
In Recent years, Bacterial contamination changes physical and chemical properties of 
cosmetics usually resulting in phase separation, discoloration and release of odours etc. Rich 
composition of modern cosmetics in combination with aqueous formulation and direct 
exposure to bacterial skin flora make them an ideal environment for microbial growth. 
Taking into consideration the high risk of contamination and therefore a risk for consumers 
health, the use of preservatives is a necessity.   
Preservation systems prevent and control the growth of microorganisms from contamination 
during manufacturing, storage or consumer use. Completely preservative-free and microbial 
stable cosmetics are made by sterile production and appropriate packaging. However, 
satisfactory results can be achieved only for some formulations and are under certain 
restrictions. 
Preservative systems usually include various combinations of chemical biocides that operate 
on a broad spectrum of bacteria and fungi. They offer a high antimicrobial efficacy and 
therefore prolong the shelf-life of products, however, many of them can cause adverse 
reactions to skin. 
A promising strategy to overcome these problems involves the development of suitable drug 
carrier systems. Nowadays, essential oils are the subject of intensive scientific research and 
also attract attention of cosmetic and pharmaceutical industries due to their potential 
therapeutic benefits as well as natural preservation effect. A new promising field of 
application of essential oils as natural preservatives in cosmetics or feed additives in human 
or animal food or as plant protection products has been studied. It is estimated that more than 
3000 essential oils are of commercial importance and used in flavor and cosmetic industries. 
The microbial safety of cosmetics has been always of special interest for industries, as 
microbial spoilage can lead to product degradation and cause a risk to consumer’s health. 
It has become more and more evident that the development of new drugs alone is not 
sufficient to ensure progress in drug therapy. Exciting experimental data obtained in vitro are 
very often followed by disappointing results in vivo due to poor drug solubility, poor 
absorption, rapid metabolism and elimination, high fluctuation of plasma levels due to 
unpredictable bioavailability after per oral administration.  
The carriers should permit a controlled and localized release of the drug according to the 
specific needs of the therapy which determines the in vivo fate of the drug. The size of the 
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carrier depends on the desired route of administration and ranges from few nanometres to the 
micrometer. 
 Nano structured lipid carriers are proved to be suitable carriers with various 
advantages like (i) controlled release of the drug (ii) increased drug stability (iii) high drug 
loading (iv) no bio toxicity of the carrier (v) avoidance of organic solvents and (vi) no 
problems with respect to large scale production and sterilization. 
Based on these facts, the aim of this work is to present current knowledge on essential oils 
with special focus on mechanism of antimicrobial action; assessment of their efficacy as 
preservatives in cosmetic formulations as well as their safety is carried out with the following 
objectives.  
 
 Selection of Natural Preservatives/ Oils 
 Optimization of Natural Preservatives/ Oils in various Bacterial strains. 
 Determine the Minimum inhibitory Concentration of essential oils. 
 The specific objective of the present work is to develop nano structured lipid carriers 
(NLC’s) loaded with Niacinamide using Natural Preservatives (Natural Essential 
Oils). 
 To develop lipid based cosmeceuticals NLC using Niacinamide. 
 To evaluate the physical and texture properties of the formulations. 
 To characterize the prepared formulations. 
 To evaluate the stability of the formulations over long term at room temperature. 
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REVIEW OF LITERATURE 
NANO STRUCTURED LIPID CARRIERS; POTENTIAL DRUG CARRIERS 
In the pharmaceutical breakthrough today, the new technologies lead to find 
numerous new mighty compounds. To double-check progress in drug therapy the 
development of new drugs solely is not sufficient. Poor water solubility and insufficient 
bioavailability of the new drug substances are very widespread issues encountered. Thus, 
there is an expanding need to develop a pharmaceutical carrier scheme that overcomes these 
matters. This carrier scheme should be free of toxicity, have an adequate pharmaceutical 
loading capability and the possibility of pharmaceutical targeting and controlled release 
characteristics. The system should provide chemical and personal steadiness for the 
incorporated pharmaceutical. The feasibility of the production technique and as well the 
affordability should also be accessible. 
SLN have been presented as an alternate carrier scheme to emulsions, liposomes and 
polymeric nanoparticles. SLN are formulated from solid lipids only. Therefore, after 
groundwork at smallest a part of the particles crystallizes in a higher energy modification (α 
or β`). Throughout storage, these modifications can transform to the low power, more 
organised β modification. Due to this modification high degree of alignment, the number of 
imperfections in the crystal lattice is small; this directs to drug expulsion .NLC have been 
developed to overwhelm the drawbacks affiliated with SLN. They are advised to be the 
second lifetime of lipid nanoparticles. Contrasted to SLN, NLC show a higher loading 
capability for hardworking compounds by conceiving a less organized solid lipid matrix, i.e. 
by blending a fluid lipid with the solid lipid, a higher element drug stacking can be achieved. 
NANO TECHNOLOGY AND NANO MEDICINE 
Nanotechnology is extremely valuable in the development of advanced therapeutic 
systems, which are termed “nanomedicines”. In particular, drug delivery systems using 
nanoparticles area promising approach to improving the safety and bioavailability of drugs. 
Strongly lipophilic compounds are not generally applicable in aqueous biological systems. 
However, even if a drug is water insoluble, drug delivery materials permit its solubilization in 
the form of nanoparticle dispersions. Furthermore, targeted delivery of drugs to tissues and 
cells, as well as controlled release of the drug, are possible by varying the properties of these 
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nanoparticles.Thus, nanoparticulate drug delivery systems may lead to the development of 
novel therapeutic agents toward nanomedicine. 
Approaches for the Development of Solid and Semi-Solid Lipid-Based Formulations 
Lipid Based Drug Delivery (LBDD) has developed over the past decade fuelled by a 
better understanding of the multiple roles lipids may play in enhancing oral bioavailability. 
Moreover, the emergence of novel excipients with acceptable regulatory and safety profiles 
coupled with advances in formulation technologies have greatly improved the potential for 
successful lipid based formulations. With the growing interest in this field, there is an 
increasing need for guidelines in excipient selection and characterization; material handling, 
formulation design, and processing techniques to obtain effective and patient-compliant 
dosage forms. V. Jannin et al 2007 present the recent approaches in selecting the most 
appropriate lipid system(s); methods for characterization of their behaviour in vitro and in 
vivo. 
Nutraceuticals 
          The term nutraceuticals was originally defined by Dr. Stephen L. DeFelice, founder 
and chairman of the Foundation of Innovation Medicine (FIM), Crawford, New Jersey. Since 
the term was coined by Dr.DeFelice, its meaning has been modified by Health Canada which 
defines nutraceuticals as: a product isolated or purified from foods, and generally sold in 
medicinal forms not usually associated with food and demonstrated to have a physiological 
benefit or provide protection against chronic disease. Examples are beta carotene and 
lycopene. Dr Stephen DeFelice coined the term "Nutraceutical" from "Nutrition" and 
"Pharmaceutical" in 1989. The term nutraceutical is being commonly used in marketing but 
has no regulatory definition. An attempt to re-define nutraceuticals and functional foods is 
made in this article. The proposed definitions can help distinguish between functional foods, 
nutraceuticals, and dietary supplements. Nutraceuticals and dietary supplements. The 
advantages and disadvantages of nutraceuticals are also briefly discussed. Many 
nutraceuticals, functional foods and naturally occurring compounds that have been 
investigated and reported in various studies revealed that these products are extremely active, 
have profound effect on cell metabolism and often have little adverse effect. It is natural that 
people focus is shifting to positive approach for prevention of diseases to stay healthy. 
Nutraceuticals is scientific area generated all over the world. In many cases nutraceuticals off 
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advantage over the synthetic drugs under development by the pharmaceuticals industry. It is 
novel pharmacological activity that are become interesting in their possible clinical use and 
thus helping in prevention and therapeutic in several diseases. 
Nutraceuticals is a broad umbrella term used to describe any product derived from food 
sources that provides extra health benefits in addition to the basic nutritional value found in 
foods. Products typically claim to There is minimal regulation over which products are 
allowed to display the nutraceuticals term on their labels. Because of this, the term is often 
used to market products with varying uses and effectiveness. The definition of nutraceuticals 
and related products often depend on the source. Members of the medical community desire 
that the nutraceuticals term be more clearly established in order to distinguish between the 
wide varieties of products out there. There are multiple different types of products that may 
fall under the category of nutraceuticals. Nutraceuticals have been claimed to have a 
physiological benefit or provide protection against the following diseases (and/or found to act 
as) 
 Cardiovascular agents 
 Antiobese agents 
 Antidiabetics 
 Anticancer agents 
 Immune boosters 
 Chronic inflammatory disorders 
 Degenerative disease 
Cosmeceuticals 
Introduction 
          The word “cosmetic” is derived from the Greek word “Kosmos” meaning “to arrange”. 
In the late 10,000 BC, cosmetics were very important in Egyptian health and Hygiene. 
Tracing the origin of cosmetics, the first recorded use of cosmetic is attributed to Egyptians, 
Cirea 4000 BC.cosmeceuticals are cosmetic products with biologically active ingredients 
purporting to have medical or drug like benefits. A cosmeceutical is an ingredient with 
medicinal properties that manifests beneficial topical actions and provides protection against 
degenerative skin conditions. The word “cosmeceuticals” was popularized by Albert 
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M.Kligman in the late 1970s. It encompasses cosmetic actives with therapeutic, disease 
fighting, or healing properties, serving as a bridge between personal care products and 
pharmaceuticals ,like cosmetics , cosmeceuticals are topically applied ,but they contain 
ingredients that influence the biological function of skin.comeceuticals improve appearance 
by delivering nutrients necessary for healthy skin. Cosmeceuticals typically claim to improve 
skin tone, texture and radiance, while reducing wrinkling. Cosmeceuticals are the fastest-
growing segment of the natural personal care industry.  
Some of the other medication applications of the cosmeceutical products are:  
• Anti-fungal & Anti-Bacterial 
 • Skin-Whitening Agent 
• Anti-acne Agents 
 • Soothing, Smoothing, Moisturizing or Protective Agents (such as calamine)  
• Under eye dark circle  
• Anti-Ageing & Anti-Wrinkle 
Niacinamide 
Niacin is a water-soluble vitamine, also known as vitamine B3.niacin is the generic term for 
nicotinic acid (pyridine 3-carboxylic acid) and nicotinamide (nicotinic acid amide) and the 
coenzyme forms of the vitamine.  Nicotinamide is active form, which functions as a 
constituents of two coenzymes, namely, nicotinamide adenine dinucleotide(NAD) and 
nicotinamide adenine dinuclotide phosphate(NADP). In the forms of these coenzymes, niacin 
functions in many biological redox reactions which activate about 200 dehydrogenase 
essential to electron transport and other cellular respiratory reactions.NAD functions as an 
electron carrier for intracellular respiration as well as a cofactor for enzymes involved in the 
oxidation (catabolism) of fats, protein, carbohydrates and alcohol to produce energy. NADP 
functions as a hydrogen donor in reductive biosynthesis(anabolism), such as in fatty acid and 
steroid synthesis. Like NAP, NADP is a cofactor for enzymes, such as in the oxidation of 
glucose-6-phosphate to ribose-5-phosphate in the pentose phosphate pathway. 
In non-redox reactions NAD is the substrate for two classes of enzyme that separate the 
niacin moiety from NAD and transfer ADP –ribose to proteins. A third classes of enzymes 
catalyses the formation of cyclic ADP-ribose. This molecule also functions within cells to 
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provoke the release of calcium ions from internal storage sites and may also plays a role in 
cell-signaling.                                                                                                                               
Nano Structured lipid carriers (NLC) 
Solid lipid nanoparticle (SLN) and nanostructured lipid carrier (NLC) are colloidal 
lipid systems, which have been proposed for several administration routes, such as parenteral, 
oral and topical route providing controlled release profile of many substances. Solid lipid 
nanoparticle (SLN) has the chance to be exploited as a delivery system in commercial 
products. However, there are some limitations of the solid lipid nanoparticles (SLN) system: 
Drug expulsion phenomenon when lipid crystallizes to the stable β-form, particle 
concentration in the aqueous dispersions ranging from about 1% to a maximum of only 30% 
and limitation of drug load by the solubility of the drug in the solid lipid(A.C. 
Silva,Aakanchha Jain et al.,2011). These limitations were solved by creating a lipid particle 
with a controlled nanostructure i.e the nano structured lipid carrier (NLC). 
SLN consists of pure solid lipids and NLC contains a certain percentage of additional 
liquid lipids leading to imperfections in the crystal lattice. These nanoparticles are produced 
by one of the following techniques, namely, high pressure homogenization, microemulsion 
template, cold homogenization, solvent emulsification, solvent diffusion, reverse micelle-
double emulsion, homogenization followed by ultrasonication, solvent injection and a very 
recently introduced membrane contractor techniques(Amichand Dairam et al.,2008) 
The suitability of solid lipid nanoparticles (SLN) for the encapsulation of lipophilic 
drug was assessed for oral administration. The hot high pressure homogenization (HPH) 
technique was used as production method for SLN. Mechanical approaches are capable of 
producing nanoparticles, typically in the 100–1000 nm range, whereas chemical methods 
tend to produce 10–100 nm particles.(A.C. Silva et al.,2011) 
Nanotechnology is an enable technology that has the potential to revolutionize drug 
and food systems. Nanotechnology have shown enhanced oral bioavailability and biological 
efficacies of different phytochemicals(HuangQ et al. 2010) 
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ANTIBACTERIAL ACTIVITY OF ESSENTIAL OILS AND POTENTIAL 
APPLICATIONS IN FOOD 
Essential oils are aromatic oily liquids obtained from plant material (flowers, buds, seeds, 
leaves, twigs, bark, herbs, wood, fruits and roots). They can be obtained by expression, 
fermentation or extraction but the method of steam distillation is most commonly used for 
commercial production of EOs (Helander .I M et al.,1998).The term 'essential oil' is thought 
to derive from the name coined in the 16th century by the Swiss reformer of medicine. An 
estimated 3000 EOs are known, of which about 300 are commercially important – destined 
chiefly for the flavours and fragrances market. It has long been recognised that some EOs 
have antibacterial properties and these have been reviewed in the past that spices have 
antibacterial properties. Besides antibacterial properties, EOs or their components have been 
shown to exhibit antiviral, antimycotic, antitoxigenic, antiparasitic, and insecticidal 
properties. 
 
The greatest use of EOs in the European Union (EU) is in food (as flavourings), perfumes 
(fragrances and aftershaves) and pharmaceuticals (for their functional properties). The well-
known use of EO in aromatherapy constitutes little more than 2% of the total market. 
Individual components of EOs are also used as flavourings, either extracted from plant 
material or synthetically manufactured. The antibacterial properties of essential oils and their 
components are exploited in such diverse commercial products as dental root canal sealers, 
antiseptics and feed supplements for lactating sows and weaned piglets. A few food 
preservatives containing Eos (Sara Ann Burt et al.,2007).  
Recently there has preservative and antimicrobial role of spices has been an 
increasing interest in discovering new natural prevention of meats. Bio preservatives include 
a range of natural plants, animals and microorganisms which can be used to improve the 
keeping quality of foods. Being plant natural food stuffs, spices appear to be an alternative 
for the chemical antimicrobials to the consumers who tend to question their safety. Spices 
active compounds have been included in class of naturally occurring food preservatives and 
their inclusion in foods allowed by food production regulatory offices. Although, spices have 
been well known for their medicinal, preservative and antioxidant properties, currently they 
have been used with primary purpose of enhancing the flavour of foods rather than extending 
shelf-life. In recent years antimicrobial properties of spices have been documented and 
interest continued to the present. There is little information available emphasizing the 
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preservative and antimicrobial role of spices in the prevention of meat (A.Jagadeesh Babu et 
al.,2011)  
 
MECHANISM OF ANTIMICROBIAL ACTION OF ESSENTIAL OILS 
 
Antimicrobial activities of EOs are well known and documented in numerous works. They 
are effective against both saprophytic bacteria and fungi, which are main source of cosmetic 
contaminations (Bacillus sp., Micrococcus sp., Aereomonassp., Acinetobacter sp. and 
Aspergillus sp. or Penicillium sp.) and also against human pathogens (Staphylococcus sp., 
Streptococcus sp., Salmonella sp. or Candida sp. And others). In contrast to antimicrobial 
activity of EOs mechanisms of their action are still not fully understood and need elucidation. 
In general, antimicrobial activity of essential oils is determined by their composition and 
concentration of components. The number of constituents in essential oil can range from 
several up to far more than 100. Composition and proportion of compounds varies and 
depends on chemotype, age of a plant, climatic and environmental conditions as well as 
harvest time and the distillation method. Essential oils are a complex and diverse group of 
natural compounds that usually consist of terpenes with terpenoids, and also aromatic and 
aliphatic compounds of low molecular weight. Monoterpenes are the most commonly found 
molecules constituting 90% of essential oils in a great variety of structures. Aromatic 
compounds are represented less frequently, usually in trace amounts. EOs composition is 
often characterized by two or three main compounds at higher concentrations (20–70%), 
which determine biological properties of essential oil. 
 
EFFICACY OF ESSENTIAL OILS AS PRESERVATIVES IN COSMETIC 
FORMULATIONS 
 
Efficacy of preservatives in cosmetic formulations is evaluated in a challenge test according 
to the European Pharmacopoeia guidelines. The challenge test is a standard procedure that 
involves artificial contamination of cosmetics with predetermined number of bacteria and 
fungi (105-106 viable cells ml-1 or g-1 of product) as well as periodic removal of samples at 
fixed time for counting of viable microorganisms present in the formulation during test. 
Microorganisms used in the challenge test include strains of bacteria: Staphyllococcus 
aureus, Pseudomonasaeruginosa, Escherichia coli and fungi: Aspergillus niger and Candida 
albicans. According to EP, a topical preparation is well preserved if the number of the 
bacteria recovered per gram is reduced by a factor of 103 (criteria A) and 102 (criteria B) 
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within 2 days of the challenge test with no cell proliferation at 7th day up to the 28th day 
(Mariola Dreger, Karolina wiergus et al.,2013). 
The present investigation is focused on the development of niacinamide loaded NLC and 
assessment of essential oil preservation system for cosmeceutical formulation containing 
niacinamide NLC.  
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PLAN OF WORK 
 Preformulation Studies 
 Preparation of Calibration Curve for Niacinamide by UV Visible 
Spectrophotometric Analysis. 
 IR Spectroscopic Analysis. 
 Selection of Natural Preservatives/ Oils 
 Optimization of Natural Preservatives/ Oils in various Bacterial strains. 
 Determine the Minimum inhibitory Concentration of essential oils. 
 
 Formulation Development 
 Formulation of nano structured lipid carrier using Ultra probe sonication 
technology. 
 Formulation of Base Cream. 
 Incorporation of NLC into Base. 
 Characterization studies of the Niacinamide loaded NLCs Cosmeceutical 
 Particle Size Determination by Zeta sizer  
 Entrapment Efficiency 
 Microbial Studies 
 Atomic Force Microscopy(AFM) 
 Scanning Electron Microscopy(SEM) 
 Phase Contrast Microscopy(PCM) 
 In vitro skin penetration 
 Texture Analysis 
 Stability Studies as per ICH guidelines 
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MATERIALS USED 
Table 1: Materials Used 
SL.NO. MATERIALS SOURCE 
1. Niacinamide Veer Chemie aromatics 
2. Saponin Maddi Pharmaceuticals 
3. Compritol Gattefosse 
4. Soya lecithin Loba Chemie Pvt. Ltd., Mumbai 
5. Glyceryl mono stearate Loba Chemie Pvt. Ltd., Mumbai 
6. Cocoa Butter National chemicals,vadodara,Gujarat 
7. Cinnamon oil pure 
Sangrose Laboratories Pvt. Ltd., 
Mavelikara 
8. Distilled Water Himedia Lab., Mumbai 
9. 
 Muller Hinton Agar Himedia Lab., Mumbai 
 
 
 
 
 
 
 
Materials & Equipments  
 
22 
 
 
 EQUIPMENTS USED 
Table 2: Equipments Used 
SL.NO. EQUIPMENT MODEL/COMPANY 
1. Digital Weighing Balance Shimadzu AY 220 
2. Magnetic Stirrer Remi Equipments Ltd 
3. Bath Sonicator RP 120 Ralsonics, Mumbai 
4. Ultra Probe Sonicator SONICS vibracell 
5. UV Visible Spectrophotometer UV-1650 PC Shimadzu 
6. FT IR Spectrophotometer 8400 S Shimadzu 
7. IR Hydraulic Pellet Press Model M15 Technosearch Instruments 
8. ELIZA reader Thermo Scientific 
9. Scanning Electron Microscope JEOL, Japan- JSM 6360 
10. Atomic Force Microscope  Multimode Scanning probe microscope 
(NTMDT, NTEGRA prima, Russia) 
11. Zeta Sizer Nano ZS90 Malvern UK 
12. Texture Analyzer TA-XT Plus 
13. Phase Contrast Microscope NIKON Inverted Fluorescent Microscope 
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DRUG PROFILE 
NIACINAMIDE 
Chemical name                    :   pyridine-3-carboxamide 
Formula       :   C6H6N2O 
Structure   :  
Molecular weight  :122.127g/mol 
 
Physical state   :  Solid 
Melting point   :  130 °C 
Solubility             :   Water solubility 83.1mg/ml .  
                                                     Very soluble in ethanol ,  slightly soluble in chloroform. 
Density                                   :    1.4 g/cm³                           
Log P    :     0.29 
Log S    :    -0.17 
Pka                                  :      3.35(at 20 °C)  
Hydrogen acceptor count :      3 
Hydrogen donor  :      1 
Pharmacological actions :      It has got many potent pharmacological actions like    
antipruritic, antimicrobial, vasoactive, photo-protective,  
sebostatic and lightening effects depending on its 
concentration. niacinamide controls the NFκB-mediated 
transcription of signalling molecules by inhibiting the 
nuclear poly (ADP-ribose) polymerase-1 (PARP-1).  
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EXCIPIENTS PROFILE 
COMPRITOL 
Synonyms : glyceryl behenate 
Chemical Name : 2,3-dihydroxy propyl docoanoate.  
Empirical Formula : C25H50O4 
Molecular Weight : 414.671g/ml  
Functional Category : Emulsifying agent; solubilising agent; tablet and capsule    
lubricant. 
Applications  : Glyceryl behenate is a fat used in cosmetics, foods, and 
oral pharmaceutical formulations. In cosmetics, it is mainly used 
as a viscosity-increasing agent in emulsions. 
Description :  Compritol® 888 ATO is an inert, tasteless/odorless, hydrophobic 
white powder used in formulation of solid oral dosage forms.. 
Melting point :  65–77°C 
Solubility  :  Glyceryl bebenate is soluble when heated, in chloroform and 
dichlromethane. It is practically insoluble in ethanol(95%), 
hexane, mineral oil and water 
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COCOA BUTTER 
 
Synonyms  : Cocoa oil, Cocoa fat, Cocoa bean oil 
Chemical name                   :     1,3-dipalmitoyl- 2-oleoyl-glycerol (POP), 1-palmitoyl- 
2-oleoyl-3-stearoyl-glycerol (POS), and 1,3-stearoyl-2-     
oleoyl-glycerol 
Empirical formula  : CH3(CH2)16COOH 
Structural formula  : 
 
Description  : Yellow in colour 
Melting point  : 34.1°C (93.4° F) 
Solidify  : Solidify at 20°C  
Refractive index  : 1.44556- 1.44573 
Iodine value  : 32.11- 35.12 
Acid value  : 1.68 
Saponification value  : 191.214 
Functional category  : It is used in lotions and skin care products like cream, facial 
washes, etc.,  
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GLYCERYL MONOSTEARATE 
Synonym              :  Glyceryl monostearate, Glycerin monostearate, Monostearin 
Chemical name  :  2,3-Dihydroxypropyl octadecanoate 
Empirical formula  :  C21H42O4 
Molecular weight  :  358.56 g·mol−1 
Structural formula  : 
 
  
Description             :   A white or yellowish white, hard waxy mass or unctuous  
    powder orflakes; odourless or slight, agreeable, fatty odour. 
 
Boiling point             :   238 to 239 °C  
Melting point             :   58 to 59 °C  
Functional category            :    GMS is a food additive used as a thickening, emulsifying,  
anti-caking, and preservative agent; an emulsifying agent for           
oils, waxes, and solvents; a protective coating for 
hygroscopic powders; a solidifier and control release agent 
in pharmaceuticals; and a resin lubricant. It is also used in 
cosmetics and hair care products.It is responsible for 
giving ice cream and whipped cream its smooth texture. It is 
sometimes used as an anti-staling agent in bread. 
Storage   :    Glyceryl monostearate should be kept in a tightly closed  
                                                     container, protected from light. 
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CINNAMON OIL 
Synonym                                : Cassia oil, Chinese cinnamon,Cassia bark oil, Oil of cassia   
Chemical name  : 2-methoxy-4-prop-2-enylphenol;[(E)-prop-1-enyl]benzene 
 
Empirical formula  : C19H22O2 
Molecular weight  : 282.383 g/mol 
Structural formula  :  
 
 
Description  :    It is of a golden-yellow colour, with the characteristic odour  
of cinnamon and a very hot aromatic taste. The pungent and    
scent come from cinnamaldehyde (about 90% of the essential 
oil from the bark) and, by reaction with oxygen as it ages, it 
darkens in colour and forms resinous compounds. 
Boiling point   :    194-234 °C 
 
Solubility   :    Insoluble in water, soluble in alcohol  
Functional category  :    Effective at treating skin conditions such as rashes, acne and  
infections, you can mix cinnamon essential oil with a 
carrieroil (like coconut oil) and apply it to the skin to take 
advantage of its antimicrobial capacity. 
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PREFORMULATION STUDIES 
Preformulation studies involve physical, chemical and biological characterization of 
new drug substances in order to develop stable, safe and effective dosage form. 
Preformulation testing encompasses all studies enacted on a new drug compound in order to 
produce useful information for subsequent formulation of a stable and bio-pharmaceutically 
suitable drug dosage form. 
Analytical methods for Niacinamide 
 UV Spectrophotometric estimation of Niacinamide  (European Pharmacopoeia 6.0) 
Determination of lambda max: 
Niacinamide: 
A concentration of 100μg/ml solution of Niacinamide, were prepared and scanned 
under UV Visible Spectrophotometer from 200 to 400nm. The corresponding peak with the 
highest absorbance was taken as the lambda max for quantifying Niacinamide.  
Niacinamide standard solution (100μg/ml) showed highest peak at 261nm. From the 
UV-Vis spectrum (Graph 1) the lambda max of the Niacinamide was optimized as 261nm 
and used for further studies. 
Lambda max of Niacinamide:  
Fig 3 :  UV Spectrum of Niacinamide 
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Standard graph for Niacinamide 
 Primary stock solution of Niacinamide was prepared by dissolving 100mg of 
Niacinamide in 100ml of methanol in a volumetric flask. Aliquots of Niacinamide was 
prepared from stock solution in the concentration range of 1 μg/ml, 2 μg/ml, 3 μg/ml, 4 
μg/ml, 5 μg/ml, 6 μg/ml, 7 μg/ml, 8 μg/ml, 9 μg/ml and 10 μg/ml in 100ml volumetric flask 
using water as solvent. The absorbance of Niacinamide standard solutions was measured at 
261 nm (lambda max of Niacinamide) against water as blank. The standard graph was 
prepared with concentration of solution (in µg/ml) on X-axis and absorbance on Y-axis. The 
results are shown in fig 4. 
Table 3: Standard Table for Niacinamide 
Sl.no Concentration (µg/ml) Absorbance at 262nm 
1.  1 0.039 
2.  2 0.048 
3.  3 0.073 
4.  4 0.102 
5.  5 0.129 
6.  6 0.166 
7.  7 0.175 
8.  8 0.199 
9.  9 0.222 
      10.   10 0.255 
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Fig 4: Calibration Curve of Niacinamide 
 
 
 
 
 
 
 
EXPERIMENTAL METHODOLOGY 
Compatibility studies 
The sample of Niacinamide of about 10mg was mixed with 100mg of KBr to make 
the pellet and scanned under FT-IR spectroscopy from 400 – 4000 cm-1. 
IR Spectrum of Niacinamide  
Characteristic peaks for carbonyl group C=O stretching was observed in 1681 cm-1and N-H 
Amide Stretching at 3368 cm-1 which is evident that two peaks are confirming the purity of 
Niacinamide molecule. 
Fig 5 :  IR Spectra of Niacinamide 
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IR Spectrum of Saponin  
Characteristic peaks for carbonyl group O-CH3 stretching was observed in 1047 cm-1and C-
H bond with benzene Stretching at 678 cm-1 and sharp peak indicate geometrical cis-isomer 
stretching was observed in 999 cm-1 which is evident that three peaks are confirming the 
purity of saponin molecule. 
 
 Fig 6 :  IR Spectra of Saponin 
 
 
IR Spectrum of compritol  
Characteristic peaks for carbonyl group C=O stretching was observed in 1739 cm-1and C-H 
Stretching at 2849 cm-1 which is evident that two peaks are confirming the purity of 
compritol molecule. 
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                              Fig 7 :  IR Spectra of Compritol 
 
 IR spectra of physical mixture niacinamide, saponin and compritol 
Characteristic peaks for carbonyl group C=O stretching was observed in 1653 cm-1and C-H 
Stretching at 2900 cm-1 and N-H amide Stretching at 3379 cm-1 and C-H bond with benzene 
Stretching at 998 cm-1 which is evident that four peaks are confirming the purity of physical 
mixture niacinamide, saponin and compritol molecule. 
Fig 8 :  IR spectra of physical mixture niacinamide, saponin and compritol 
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PREPARATION OF PLANT MATERIAL FOR SAPONIN DETERMINATION  
   The rinds of healthy ripe fruits of Sapindus mukorossi were sun dried. The dried samples 
were then crushed with mortar and pestle before grinding into fine powder using a manual 
grinder.  
QUALITATIVE DETERMINATION OF SAPONIN 
The homogenous samples of sapindus mukorossi was subjected to phytochemical analysis for 
qualitative determination of saponin .The performed qualitative tests were briefly described 
as: 
In a test tube 0.5g og the extract was shaken with water. A stable frothing was taken as a 
evidence for the presences of saponin. 
The following ranking was used; 
       + = Present  
QUANTITATIVE DETERMINATION OF SAPONIN 
     Air-dried powdered pericarp of Sapindus mukorossi(5g) was extracted by maceration in 
methanol at 50°C for 12hours at a solid/liquid ratio of 1/20(w/v).After filtration and 
evaporation of the methanol extract, the gummy residue was suspended in 50mL water and 
extracted successively with 100mL ethyl ether three times. After removing the remaining 
ethyl ether in the aqueous layer by evaporation, the solution was further extracted 
successively with 100mL, and 50mL n-butanol respectively, then, the n-butanol fraction was 
dried by evaporation. The resulting product (1.57g) is referred to as the organic extract of 
crude saponin. 
The saponin content was calculated by using the following formula. 
Percentage of saponin= (final weight of sample/initial weight of extraction) ×100 
Percentage of saponin= (1.57/5) ×100 
Percentage of saponin=31.4% 
SELECTION OF OILS 
Various Essential oils have been widely used for bactericidal, virucidal, fungicidal, 
ant parasitical, insecticidal, and other medicinal properties such as analgesic, sedative, anti-
inflammatory, spasmolytic, and locally anesthetic remedies. Essential oils  such as Neem 
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oil,Clove oil,Eucalyptus oil,Orange oil,Peppermint Oil,Lemon grass Oil,Castor oil,Lavender 
Oil, Olive oil, Cinnamon oil tested for antibacterial activity against 7 Bacterial Strains.  
(Staphylococcus aureus, Enterococcus faecalis, Streptococcus aeruginosa, Salmonella 
typhimurium, E.coli, Klebseilla pneumonia,Candida albicans). 
Various 
Essential 
oils 
Strains 
Staphylococcus 
Aureus  
Solmonella 
typhimurium 
Enterococcu
s faccalis 
Pseudimonas 
aeroginosa 
E.coli Klebsiella 
pneumonia 
Candida 
albicans 
Neem oil 
Oil 
-- -- -- - -- -- -- 
Clove Oil     -       - 
Eucalyptu
s Oil 
    -       - 
Orange 
Oil 
- - - - - - - 
Peppermin
t Oil 
    -       - 
Lemon 
Grass Oil 
-   -         
Castor Oil - - - - - - - 
Lavender 
Oil 
    -         
Olive Oil - - - - - - - 
 
Table 4:Antibacterial activity of Essential Oils 
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 Fig 9 : Images Of Zone Of Inhibition For Essential Oils 
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Among this clove oil, peppermint oil, lemon grass oil, lavender oil, Cinnamon oil have well 
effect against bacteria.Neem oil has less bacterial activity presents in the active constituent of 
neem bark oil other than that it has fungal activity. 
Mixed proportions of essential oils were studied for antimicrobial activity for E.Coli 
and Klebsiella strains 
Clove Oil + Eucalyptus Oil Clove Oil + Lavender Oil 
Clove Oil + Peppermint Oil Eucalyptus Oil + Peppermint Oil 
Peppermint Oil + Lavender Oil Clove Oil + Eucalyptus Oil + 
Peppermint Oil 
Clove Oil + Eucalyptus Oil + 
Peppermint Oil + Lavender Oil 
Clove Oil + Eucalyptus Oil + 
Peppermint Oil + Neem Oil 
Clove Oil + Eucalyptus Oil + 
Peppermint Oil + Lavender Oil + 
Neem Oil 
Cinnamon Oil + Neem Oil 
 
Table 5: Mixed Proportion Of Essential Oils 
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    Fig 10: Images of Zone of Inhibition For Mixed Proportion 
Here combination of oils shows lesser antibacterial activity than individual. 
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DETERMINATION OF MINIMUM INHIBITORY CONCERNTRATION 
Method: 1 
 MIC determinations were performed in 96-wellmicroplates according to procedures 
described by the Clinical and Laboratory Standards Institute. The liquid media was prepared 
by adding 2% peptone, 0.5% Nacl, 0.3% beef extract in 100ml distilled water. Then 100µl 
liquid media was transferred into micro plate well. 100µl of essential oil were added in first 
well then serial two fold dilution was made. Add 5µl inoculum in each well.  The positive 
control comprised of media and organism and the negative control was liquid media. 
Inoculated micro plate were incubated for 24hrs at 37°C. Then absorbance were measured 
spectrometrically at 625 nm.    
      
Control Absorbance 
Media 0.0470 
Media + Organism 0.1156 
  
 
Essential 
oil 
 
1 
 
2 
 
3 
 
4 
 
5 
 
6 
 
7 
 
8 
 
9 
 
10 
 
11 
 
Cinnamon 
oil 
 
0.195
61956 
 
0.496
6 
 
0.407
40.40
74 
 
0.240
60.24
06 
 
0.092
10921 
 
0.091
3913 
 
0.077
70.07
77 
 
0.084
3843 
 
0.075
1 
51 
 
0.092
8928 
 
0.071
1.071
1 
 
Eucalyptus 
oil 
 
0.056
8 
 
0.079
1 
 
0.073
6 
 
0.076
8 
 
0.078
6 
 
0.099
9 
 
0.160
6 
 
0.143
2 
 
0.141
7 
 
0.131
4 
 
0.138
2 
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Peppermint 
oil 
 
0.619
7 
 
0.158
7 
 
0.096
8 
 
0.096
2 
 
0.090
2 
 
0.120
1 
 
0.107
1 
 
0.122
5 
 
0.124
4 
 
0.144
3 
 
0.129
1 
 
Lavender 
oil 
 
0.228
5 
 
0.114
4 
 
0.142
5 
 
0.078
3 
 
0.136
8 
 
0.197
0 
 
0.175
2 
 
0.227
2 
 
0.198
1 
 
0.259
4 
 
0.126
8 
 
Table 6:  Minimum inhibitory concentration for essential oils  
 
Method: 2  
 
All microbiological assays were performed under anaerobicconditions. MIC 
determinations were performed in 96-wellmicroplates according to procedures described by 
the Clinical and Laboratory Standards Institute. Each essential oil (200mg) was dissolved in 
dimethyl sulfoxide (40µL) and thevolume was made to 5 mL with sterile Muller Hinton 
medium containing 1%Tween 80 to provide a stock solution containing 40 mg mL–1of oil. 
Serial twofold dilutions of each essential oil stockwere made with Muller Hinton medium to 
yield final concentrations ranging from 20 to 0.625 mg mL–1. The diluted samples (100 
µL)were transferred to microplate wells and mixed well withthe micropipette. The negative 
controls comprised sterile Muller Hinton medium or with dimethyl sulfoxide (at 
concentrations usedin the dilutions). In order to ascertain aseptic conditions, the control wells 
contained sterile Muller Hinton medium but withoutinoculum. The inoculated microplates 
were incubated at36 ± 1◦C for 48h under anaerobic conditions; and the bacterial growth was 
confirmed by adding 10µL of a sterile0.5% aqueous solution of triphenyltetrazolium chloride 
(TTC,Sigma–Aldrich) and incubating at 36◦C for 30min. Theviable bacterial cells reduced 
the yellow TTC to pink/red1,3,5-triphenylformazan (TPF). All assays were performed 
intriplicate. 
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Fig 11: Minimum InhibitoryConcentration for Peppermint Oil 
 
Fig12: Minimum Inhibitory Concentration for Cinnamon Oil, Lavender Oil 
                            And Eucalyptus Oil 
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EXPERIMENTAL METHODOLOGY 
Nanostructured lipid carriers (NLCs) are the second Generation solid lipid nano 
particles (SLN) composed of solid lipid matrix which are incorporated with liquid lipids. 
Among the nanostructured lipid carriers that contain solid lipids together with different liquid 
oils .The presence of liquid lipids with different fatty acid C-chains produces NLCs with less 
organized crystalline structure and therefore provides better loading capacity for drug 
accommodation. Liquid lipids are better solubilizers of drugs than solid lipids. 
Approaching nano structured lipid carrier development from an emulsion perspective 
is faced with significant challenges. Numerous research groups subsequently commenced 
research efforts to improve nano structured lipid carrier development. Most researchers have 
approached traditional emulsion techniques. 
MATERIALS 
  Saponin(sapindusmukorossi),Comprittol,CocoaButter,Glycerylmonostearate, 
Soya lecithin,Cinnamon oil. 
FORMULATION DEVELOPMENT 
Preparation of Nano Structured Lipid Carriers (NLCs) by High Shear 
Homogenization coupled with ultra probe sonication 
 The solid lipid(1000mg) of choice and the liquid lipid (0.1ml)was mixed with the drug 
(50mg) and warmed to 75°C for effective melting and mixing. Simultaneously, distilled 
water(20ml) to which the surfactant(200mg) has been incorporated is also heated to 75°C,it is 
instilled into the formulation here in. Thereafter, the aqueous part is added to the lipid part 
maintaining the temperature at 75°C, with continous stirring followed by magnetic stirring for 
20mins. The two- phase system is then sonication using probe sonicator, at 20,000rpm for 
10min followed by ultra sonication for 2 min. The prepared formulations are stored at 
refrigeration condition until further use. 
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         Fig 13 :Schematic representation of the configuration of a Ultra Probe Sonicator 
Preparation of Base Cream: 
In this study, O/W emulsion was prepared by the addition of aqueous phase to the oily 
phase with continuous agitation. To prepare the base, an lipid phase that consisted of cocoa 
butter (20gm), glyceryl monostearte (2.5gm), and cinnamon oil(0.3ml). At the same time, 
aqueous phase consisting of distilled water (50ml), soya lecithin (3.5gm), was heated to the 
same temperature. After heating, aqueous phase was added to the lipid phase drop by drop. 
Stirring was continued at 2000 rpm by the mechanical mixer for 15 min until complete 
aqueous phase was added. After the complete addition of the aqueous phase, the speed of the 
mixer was reduced to 1000 rpm for homogenization,for a period of 5 min, and then the speed 
of the mixer was reduced to 500 rpm for further 5 min for complete homogenization, until the 
emulsion cooled into room temperature. 
Incorporation of NLCs into Base Cream 
 Prepared Niacinamide loaded NLCs formulation (20ml) was incorporated into the 20g 
of Base Cream.  
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CHARACTERIZATION STUDIES 
Particle size analysis  
 Photon correlation spectroscopy: 
The prepared NLCs dispersions were diluted with water /suitable solvent and the 
sample were analyzed for particle size by photon correlation spectroscopy technique using 
Zeta sizer (Nano ZS 90), Malvern, UK.  
 Zeta potential 
The size distribution and the charge nature of the prepared solid lipid Nano particle 
loaded with cosmaceuticals was analyze using Malvern zeta seizer. The suitable dilutions of 
the dispersions were made using water and it was scanned under version 6.30 by using 
disposable sizing cuvette at the count rate of 317.5 kcps for 60 sec at the measurement 
position of 4.6mm at attenuator 10. 
Encapsulation efficiency: 
 2ml of the formulation was taken and subjected to centrifugation at 13000 rpm for 50 
min at 4°c. The supernatant was collected and the absorbance was measured at the 
corresponding lamda max of 261nm. 
 
ANTIMICROBIAL ASSAY  
Nutrient agar was prepared and poured on petriplates for the growth of bacterial 
cultures. The Test cultures such as Escherichia coli (Gram –ve), Staphylococcus aureus 
(Gram +ve) was swapping on the plates by swape method. The prepared formulation were 
made on sterile disc (20µg/ml) was added and drying in the incubator for one day. Then the 
disc was placed in agar plate and standard as control. Bacterial test culture plates were 
incubated at 32-37°c for 24 hours. The sensitivity of test organism to each formulations were 
indicated by clear zone of inhibition around the well and the diameter of the zone of inhibition 
was measured. 
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Atomic Force Microscopy 
A small aqueous drop of the Niacinamide loaded nanoparticles was adsorbed and dried to the 
surface of glass slide at room temperature. The images were examined on Multimode 
Scanning probe microscope (NTMDT, NTEGRA prima, Russia) in semi-contact mode with a 
force constant range of 0.35- 6.06 N/m and a resonating frequency range of 47- 150 KHz. The 
phase image and topology image were used to determine the morphology of the NLCs. 
Scanning electron microscopy 
Scanning electron microscope (SEM) is a type of electronmicroscope that produces images of 
a sample by scanning it with a focused beam of electrons. The electrons interact with atoms in 
the sample, producing various signals that can be detected and that contain information about 
the sample's surface topography and composition. The surface characteristics of prepared 
NLCs were examined by scanning electron microscope (SEM). The suspension was first put 
on clear glass stub, allowed to dry in air followed by coating with gold using Polaren E 5100 
sputter coater and observed under microscope at 5.5x magnification. 
In vitro drug release studies: 
 NLCs formulation 1ml was taken in Franz diffusion cell apparatus. A Pig earskin was 
placed in a Frans diffusion cell containing water as medium at room temperature. At various 
predetermined intervals i.e., 2hr, 4hr, 6hr, 8hr, 24hr, 48hr. 1ml of samples was withdrawn and 
replaced by water, to maintain the sink conditions. Cumulative % drug release in the samples 
were determined by measuring the absorbance under UV visible spectrophotometry and 
thereby extrapolating from the calibration curves. 
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Texture analysis: 
 
   Fig 14: Texture Analysis Image for Niacinamide loaded Cream 
Determination Of Spreadability Of Cream: 
The spreadability of the cream was determined by means of Texture Analyser (TA.XT plus) 
equipped with 5 kg load cell using spredability rig as fixture (figure ). This fixture consists of 
a heavy duty platform, male cone and a female cone.  The Heavy duty platform was placed on 
the base of the machine and locked in the desiredposition by tightening the screws. An empty 
femalecone sample holder was placed in the base holder. The male cone probe was attached 
above the female cone such that the male conefits almost all the wayinto the female cone 
sample holder and proper care is taken to align the cones in this position. The height of the 
male cone was calibrated against thefemale cone so that the starting point was 25.0mm above 
the female cone (2 mm form the tip of the male cone and the sample). After calibration the 
sample was placed in the female cone sample holder and the test was run. The values of 
firmness (g) and work of shear (g s) were noted down by running macros. 
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Determination of Bloom Strength 
The bloom strength of the cream was determined by means of Texture Analyser (TA.XT plus) 
equipped with 5 kg load cell using a cylindrical probe of 0.5’’ diameter as fixture (figure ). 
The sample in the container was placed centrally on the platform beneath the cylindrical 
probe. After calibrating the height of the probe, the test was commenced. A trigger force of 10 
g was used for the study. The test results are obtaining by running the macro. 
Stability studies: 
 Particle size analysis and entrapment efficiency studies were conducted for 3 month to 
evaluate the stability of the formulations. The stability studies were carried out according to 
ICH guidelines.  The NLCs formulations was stored at two different conditions i.e, 5 ± 3˚C 
(refrigeration conditions) and 25 ± 2˚C (room temperature).   
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RESULTS AND DISCUSSION 
The profound success of lipid based formulations for highly potent, lipophilic 
drug molecules have gained focus in this research field from the perspective of 
pharmaceutical industries. To increase the success rate of these lipids based 
formulations, there is a need to understand the excipients role. In this line, the present 
study is carried out to develop nano structured lipid carrier using the selected lipid 
with surfactants. 
FORMULATION DEVELOPMENT 
 Selection of Lipid 
The lipid Compritol was selected randomly based on the stability data of the 
previously formulated Niacinamide solid lipid nanoparticles. The lipid showed high 
drug encapsulation with good stability was selected for further studies. 
Preparation of Nano Structured Lipid Carrier 
Ultra probe sonicator was used to formulate NLCs of Niacinamide. Totally, 7 
formulations were prepared using one Solid lipid (Compritol), one Liquid lipid 
(Cinnamon oil), and surfactants (Saponin, Soya Lecithin). The formulae for the 
prepared NLCs were given in the table No 7. 
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                                                              Table 7: Batch specification of Niacinamide loaded NLCs 
Formulation 
Code 
 
Drug 
(mg) 
Solid Lipid 
(mg) 
Liquid Lipid  
(ml) 
Surfactant1 
(mg) 
 
Surfactant2 
(mg) 
 
Water 
(ml) 
Remarks 
NLCN1 50mg 500mg 0.5ml 50mg - 20ml Phase inversion 
NNLC2 50mg 500mg 0.5ml 100mg - 20ml *Unstable  
NNLC3 50mg 500mg 0.5ml 150mg - 20ml Creaming on storage 
NNLC4 50mg 1000mg 0.5ml 200mg - 20ml Good emulsion 
NNLC5 50mg 50mg 0.5ml 200mg - 20ml Good emulsion 
NNLC6 1000mg 200mg 0.5ml 200mg 50mg 20ml Creaming on storage 
NNLC7 1000mg 2000mg 0.5ml 200mg 1000mg 20ml Creaming on storage 
*Product is not processed for further studies due to stability issues 
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Fig 15: Formulation of Niacinamide loaded NLC 
 
PHYSICOCHEMICAL CHARACTERIZATION 
Particle Size Analysis 
The prepared nano structured lipid carrier was subjected to particle size analysis using 
Zeta sizer (nano ZS90, Malvern, UK). The formulations were sufficiently diluted with double 
distilled water prior to the measurement. The results showed that the particle size of prepared 
formulations were in the range of 83 to 686nm with good PDI.  
 The results suggest that the incorporation of different surfactant showed a difference 
in the aggregation pattern of prepared particles. This may be due to the difference in the 
solubility of lipid in surfactants 
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Table 8: Particle size measurement results of Niacinamide loaded NLCs 
 
Formulation Code 
 
Particle size 
(nm) 
Zeta potencial 
(mV) 
PDI 
NNLC 1 373.5 - 5. 84 0.575 
NNLC 3 420 0.189 10,000 
NNLC 4 83.33 - 3.52 0.257 
NNLC 5 162.3 - 6.5 0.525 
NNLC 6 686 - 10.7 0.931 
NNLC 7 71.31 - 7.15 0.413 
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Size distribution report by intensity 
 
   
Zeta potential report 
 
Fig 16: Zeta size analysis of Niacinamide loaded NLCs prepared    using Compritol, 
saponin and 0.1ml Cinnamon oil 
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Entrapment efficiency 
The drug loading into the nanoparticles was determined by subjecting the formulations to 
centrifugation at 13000 rpm for 50 mins and supernatant was separated. The amount of free 
drug in the supernatant was measured spectrophotometrically at 261nm. A high drug loading 
was observed for all the formulations. Drug payload of 89.88% was observed for the 
formulation NNLC 4. The results are depicted in table 9. 
Table 9:  Percentage entrapment of drug in NLCs 
Formulation Entrapment Efficiency (%) 
NNLC 1 83.23 
NNLC 3 57.19 
NNLC 4 89.88 
NNLC 5 84.81 
NNLC 6 81.54 
NNLC 7 80.20 
 
Phase Contrast Microscopy 
The Phase Contrast Microscope images for Niacinamide loaded NLCs formulation, 
Formulation loaded cream shows particles are uniformly dispersed and it has spherical shape. 
Fig 17: PCM images showing the morphology of Niacinamide loaded NLCs 
 
                                           Niacinamide NNLC 4 – 40X     
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Anti microbial activity  
The present study deals with the preliminary screening and comparison of 
Antimicrobial activity of prepared formulation of NLCs loaded Niacinamide. The prepared 
formulations have been tested against E.coli and S. aureus for antimicrobial activity. The 
antimicrobial activity is more in NNLC 4 against E.coli, S. aureus. The antimicrobial activity 
of NLCs was compared against standard (Gentamycin) as control.  
    
Fig 18: Anti microbial activity Images of prepared NLCs 
Table 10: Antimicrobial activity of niacin loaded NLCs 
S.no Bacterial strains Zone of Inhibition (mm) 
NNLC 4 NNLC 5 Control 
1 E.coli 14 10 29 
2 Staphylococcus 
aureus 
20 14 17 
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SCANING ELECTRON MICROSCOPY 
The surface characteristics of prepared NLCs were examined by scanning electron 
microscope (SEM). The suspension was first put on clear glass stub, allowed to dry in air 
followed by coating with gold using Polaren E 5100 sputter coater and observed under 
microscope at different magnification. 
 
 
                                        Fig 19: SEM Images of prepared NLC 
Scanning electron micrographs of NLCs are shown in the above Figures. The shape of 
the NLCs was spherical and the size of the NLCs was found within the nanometer range. 
Moreover, the micrograph also revealed the agglomeration of nanoparticles which might be 
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due to the lipid nature of the carrier and the drying process during sample preparation prior to 
SEM analysis. 
ATOMIC FORCE MICROSCOPY (AFM) 
 
 
Fig 20:2D image and 3D image of AFM analyzed particle 
Atomic Force Microscopy (AFM) study results indicate that the formulation has spherical 
Shape 
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TEXTURE ANALYSIS 
Spreadability: 
Spreadability is the ease of which a product can be spread on skin. It is commonly a 
desired characteristic of ointments, gels, creams and waxes. It is related to the firmness of a 
product and more often than not the ease of spreading is associated with a loss in firmness. A 
good gel takes less time to spread and will have high spreadability. During the test the male 
cone approaches, penetrates and moves into the gel sample for a distance of 25mm from its 
start point. As the probe penetrates across the gel the force increases until a point of 
maximum penetration depth. This force value can be taken as the firmness at this specified 
depth. A firmer sample shows a correspondingly larger area that represents the total amount 
of force required to perform the shearing process. The probe then proceeds to withdraw from 
the sample. The maximum negative peak indicates the stickiness of the sample and the 
maximum negative area is taken as the work of adhesion. A stickier sample will require a 
greater force to remove the probe, yielding a larger negative area. (Figure no21) represents a 
typical spredability graph of Niacinamide Cream. The firmness value obtained for 
Niacinamide Cream (174.393g) with force of application is (169.856g.sec). Similarly the 
stickiness value for Niacinamide loaded cream is (219.812g). 
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Fig 21: Spreadability plot for Niacinamide loaded Cream 
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Bloom Strength: 
Bloom strength is a measure of the ability of a colloidal dispersion to develop and retain a gel 
form. It is the force, expressed in grams, necessary to depress by 4 mm the surface of a gel 
with a standard 0.5" diameter cylinder probe. During the test when a trigger force of 10 g is 
attained, the probe proceeds to penetrate the cream to a depth of 4 mm. During this 
penetration the force drops at the point where the cream breaks. After this the resulting forces 
are due to continuing penetration up to the required depth. The maximum positive force (i.e. 
the rupture point of the gel) is taken as an indication of rupture strength. The distance that the 
gel penetrates before this break occurs gives an indication of the gel's elasticity, i.e. a short 
distance of penetration before break indicates a brittle gel whereas a large distance of 
penetration before rupture indicates a more elastic gel.  A typical bloom strength evaluation 
plot of Niacinamide loaded cream is shown in (figure no22). The rupture strength value of 
Niacinamide loaded cream is 6.510g. 
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Fig 22: Bloom Strength plot for Niacinamide Loaded Cream 
 
In Vitro Drug Release: 
 Table 11: In vitro Drug Release Study 
S.No Time (hrs) Cumulative % Drug 
Release 
1. 2hr 0.75 
2. 4hr 4.23 
3. 6hr 10.52 
4. 8hr 12.78 
5. 24hr 52 
6. 48hr 92.48 
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 Fig 23: In vitro permeation study across pig ear skin 
The in vitro release studies were carried up to 48 hours for the formulations and 92.42% of 
drug was penetrated through pig ear skin at 48hrs.  
 
Stability studies 
Stability studies of the formulations Niacinamide loaded NLCs cream was carried out 
for 3 months according to the ICH guidelines. The result showed that there were no 
significant changes in the cream. 
Table12: Stability studies 
Formulation Code 1 month 2 month 3 month 
NNLC 4 (room 
temperature) 
92.32nm 110.36nm 130.85nm 
NNLC 4  
(Refrigerator) 
85.25nm 90.57nm 96.51nm 
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SUMMARY AND CONCLUSION 
In general lipid based formulations face stability problems over a longer period of 
time due to microbial contamination which can often change the physical and 
chemical properties of the drugs and excipients. In the current study, an attempt was 
made to enhance the stability of Niacinamide loaded lipid based formulations for 
cosmeceutical purpose using a natural preservation system. Niacinamide loaded 
nanostructured lipid carriers were prepared for lipid based cream loaded with NLCs of 
Niacinamide were prepared to serve as a carrier for the delivery of Niacinamide for 
cosmetic purpose. 
Initially, essential oils like cinnamon oil, peppermint oil, eucalyptus oil, lavender oil, 
clove oil, lemon grass oil, castor oil, neem oil and their mixtures were evaluated for 
antimicrobial activity. The results indicated a better antimicrobial property for 
cinnamon oil. Hence, Niacinamide loaded nanostructured lipid carriers and the 
corresponding creams were prepared using cinnamon oil as liquid oil carrier. 
Niacinamide loaded NLCs were prepared from compritol, cinnamon oil and saponin 
by hot homogenization technique using ultra probe sonicator. The spherical shaped 
nanostructure lipid particles with a particle size of 83 nm showed a sustained release 
pattern across pig ear skin for around 90% of drug permeation in 48 hours. The 
prepared NLCs showed good antimicrobial activities with clear zone of inhibition.   
These Niacinamide loaded nanostructure lipid particles were loaded in a lipid based 
cream (prepared from cocoa butter, glyceryl monosterate, cinnamon oil, soya 
lecithin). Evaluation of the texture properties of the lipid cream loaded with 
Niacinamide NLCs showed good firmness and stickiness. Niacinamide NLCs and 
lipid based cream loaded with Niacinamide NLCs showed good stability during the 
initial 3 months without any microbial contamination. Long term stability studies are 
in progress to evaluate the stability of the lipid based formulations for a period of 1 
year. 
Lipid based cosmeceuticals prepared using cinnamon oil as a liquid oil can be a good 
promising natural preservative against microbial contamination and can possibly 
enhance the stability of several other lipid based cosmeceuticals loaded with different 
types of drugs.  
Summary and Conclusion  
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